What is CYCN stock price today?

Visit our real-time dashboard for the current CYCN stock price and live market data.

Is CYCN stock going up or down today?

CYCN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CYCN stock now?

The decision to buy CYCN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CYCN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CYCN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CYCN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CYCN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CYCN's P/E ratio?

P/E ratio data for CYCN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CYCN's market cap?

CYCN (Cyclerion Therapeutics Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is CYCN's price to book ratio?

Price-to-book ratio for CYCN is available on our dashboard along with other valuation metrics.

Does CYCN pay dividends?

CYCN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CYCN's dividend yield?

CYCN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CYCN stock a good long-term investment?

CYCN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CYCN's revenue growth rate?

Revenue growth data for CYCN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CYCN are available on our dashboard with complete income statement analysis.

What are the risks of investing in CYCN?

Key risks for CYCN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CYCN compare to its competitors?

Compare CYCN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CYCN's performance and positioning.

What is CYCN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CYCN with bull, base, and bear case scenarios.

What do analysts say about CYCN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CYCN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CYCN's next earnings report?

CYCN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CYCN - Cyclerion Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc (CYCN) common stock

Price Chart

Loading chart...

CYCN Key Statistics

Market Cap

$8.59M

How CYCN Compares to Peers

CYCN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
CYCN(This stock)	$8.59M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 8, 2026 at 12:35 PM EDT

Ready to invest in CYCN?

Commission-free trading available. Affiliate links.

CYCN Lician Score

5% confidence

5.0/10

Neutral

CYCN has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

5.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CYCNacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CYCN Financial Snowflake

5-axis analysis across key investment dimensions

5.0/10

Neutral

5.0

Value

Valuation vs. sector peers

5.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CYCN

Dashboard

Enter a ticker to analyze